SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Focused Visit (Follow-up) — Hatshepsut

PatientHatshepsut
Date of birth1978-02-10
IdentifiersMRN HR-AC006-SYN; SSN (made up) 000-06-9440
Document date2026-05-26
AuthorAmunet Okafor-Harrington, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Six-week review: healing after the extraction, diabetes, eye and foot screening, and cardiovascular risk. [S]

History of Present Illness

Ms. Hatshepsut returns six weeks after the extraction. The socket healed without trouble and she finished the two weeks of chlorhexidine; she is chewing on both sides again. She takes metformin 1000 mg with the evening meal without stomach upset. Her thirst and night urination have eased. She has been to two of the diabetes education and nutrition sessions and has cut down on sweet tea and dates. She would like to lose some weight to make the stairs easier, and asks about the weekly injections she has read about. Her knees hurt less since she began the strengthening exercises and the gel. [S]

ElementDetail
MouthSocket healed; chewing on both sides
DiabetesMetformin 1000 mg tolerated; two education sessions; thirst eased
Her goalClimb stairs at the sites more easily; interested in a GLP-1 medicine

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever; energy better
Ears, nose, mouth, and throatNegativeNo dental pain or swelling
GastrointestinalNegativeNo nausea, diarrhea or abdominal pain
MusculoskeletalPositiveKnee pain on stairs, better with exercises
NeurologicalNegativeNo numbness or tingling in the feet

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Ibuprofen 400 mg oral tablet, one tablet by mouth every six hours as needed for dental pain, with food, for up to one weekOne tablet every six hours as needed, with food; no more than four a dayOral route2026-04-14 to 2026-04-22completedS
Acetaminophen 500 mg oral tablet, two tablets (1 g) by mouth every six hours as needed for dental pain, alternating with ibuprofen, no more than 3 g a day, for up to one weekTwo tablets every six hours as needed; no more than six a dayOral route2026-04-14 to 2026-04-22completedS
Metformin extended-release 500 mg tablet, one tablet with the evening meal for one week, then two tablets (1000 mg) with the evening mealOne tablet with the evening meal for a week, then twoOral route2026-04-14activeS
Diclofenac sodium 1% gel, 4 g to each painful knee up to four times a day as needed4 g to each knee up to four times a day as neededTopical route2026-04-14activeS
Chlorhexidine gluconate 0.12% oral rinse, 15 mL swished for 30 seconds and spat out twice daily for two weeks after the extraction15 mL rinse twice daily for two weeksOral route2026-04-15 to 2026-04-29completedS
Semaglutide 0.25 mg subcutaneous injection once weekly (starting dose, planned for four weeks)0.25 mg once weeklySubcutaneous route2026-05-26 to 2026-06-30completedS
Atorvastatin 20 mg oral tablet, one tablet by mouth dailyOne tablet dailyOral route2026-05-26activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-05-26Body height160cmS
2026-05-26Body weight91.5kgS
2026-05-26Body mass index (BMI) [Ratio]35.7kg/m2S
2026-05-26Systolic blood pressure124mm[Hg]S
2026-05-26Diastolic blood pressure78mm[Hg]S
2026-05-26Heart rate78/minS
2026-05-26Respiratory rate14/minS
2026-05-26Body temperature36.7CelS
2026-05-26Oxygen saturation in Arterial blood by Pulse oximetry98%S

Physical Exam

Vital signs recorded on 2026-05-26; see the Vital Signs section. [S]

SystemFinding
GeneralWell; weight 91.5 kg, BMI 35.7; blood pressure 124/78, pulse 78
MouthSocket of tooth 19 healed; gums red with calculus
FeetNormal 10-g monofilament and vibration sense; dorsalis pedis and posterior tibial pulses present; no callus, ulcer or deformity
KneesCrepitus in both knees; no effusion; full range

Problems

ProblemClinical statusVerificationCodeProvenance
Painful swelling of the left lower jaw for four days, after a throbbing toothache for three weeks under a broken lower left molar; low-grade temperature, no trismus, no swelling of the floor of the mouth or neck; dental abscess suspectedresolvedconfirmed R68.84S — Synthetic presenting concern at the index visit, superseded by the dental diagnosis the next day. It echoes the dental disease reported on the mummy identified as hers (R, after the index date), without linking to it.
Acute periapical abscess of the lower left first molar (tooth 19), non-restorable, with a localized buccal vestibular swelling and no spread to fascial spaces; drained and extractedresolvedconfirmed K04.7S — Synthetic modern diagnosis; no historical claim is made.
Type 2 diabetes found on screening (hemoglobin A1c 7.6% with a random glucose of 212 mg/dL from the same sample), with thirst and waking at night to pass urine; normal kidney function and urine albuminactiveconfirmed E11.65S — Synthetic screening finding at intake; not linked to the disputed claim of diabetes on the mummy (R).
Obesity, class 2 (BMI 36.3), with type 2 diabetes and knee osteoarthritis; she wants to feel stronger and move more easilyactiveconfirmed E66.812S — Synthetic finding at intake, recorded in person-first language.
Primary osteoarthritis of both knees: pain on stairs and after standing, morning stiffness under 30 minutes, crepitus, no effusion; a clinical diagnosis without imagingactiveconfirmed M17.0S — Synthetic finding at intake; not linked to the osteoarthritis reported on the mummy (R).
Periodontitis, generalized, stage III, grade C (bone loss to the middle third of the roots, two molars lost earlier to gum disease, and A1c above 7% as a grade modifier)activeconfirmed K05.323S — Synthetic finding at the dental consultation.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
LaboratoryHemoglobin A1cEvery three months until at goal or after a change in therapy, then every six monthsDue7.6% at diagnosis six weeks ago; next at about three months
ExaminationBlood pressure (goal below 130/80)Every visitCompleted today124/78
ExaminationWeight and BMI, recorded with her permissionEvery visitCompleted today91.5 kg, BMI 35.7
Medication safetyMetformin: dose, tolerance and sick-day rulesEvery visitCompleted today1000 mg tolerated; sick-day rules reviewed
Medication safetyGLP-1 receptor agonist: dose, nausea, warning signsAt start and every visitCompleted todaySemaglutide 0.25 mg weekly started; nausea, pancreatitis, gallbladder and pregnancy advice given
Medication safetyHypoglycemia reviewEvery visitNot indicatedMetformin and semaglutide do not cause hypoglycemia on their own
ExaminationComprehensive foot examinationAt diagnosis, then yearlyCompleted todayNormal
ImagingDiabetic eye screeningAt diagnosis, then every one to two yearsCompleted todayRetinal photographs: no retinopathy
LaboratoryUrine albumin-to-creatinine ratio and eGFRAt diagnosis, then yearlyUp to dateUACR 18 mg/g and eGFR 103 at intake
LaboratoryLipid panel and ALT on a statinBaseline, then 4 to 12 weeks after starting a statinDueAtorvastatin started today; ALT 31 U/L at baseline; lipids and ALT at the next review
Self-managementDiabetes self-management education and nutrition therapyAt diagnosis, then yearlyCompleted todayTwo of four sessions attended
ExaminationDental and periodontal careAt diagnosis, then periodontal maintenance every three monthsCompleted todaySocket healed; scaling and root planing booked
ExaminationKnee pain and functionEvery visitCompleted todayBetter with exercise and gel

Goal progress:

Guideline basis: Standards of Care in Diabetes—2026 (Section 2, Diagnosis and Classification of Diabetes; Section 9, Pharmacologic Approaches to Glycemic Treatment) (2026); Obesity and Weight Management for the Prevention and Treatment of Diabetes: Standards of Care in Diabetes—2026 (Section 8) (2026); Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (Section 10) (2026); Scientific evidence on the links between periodontal diseases and diabetes: Consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International Diabetes Federation and the European Federation of Periodontology (2018); 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee (2019); CMID: Clinical Monitoring Intelligence Database, diabetes type 2, rheumatoid arthritis and osteoarthritis, and hyperlipidemia monographs (2026)

Follow-up: Preventive visit as booked; fourteen-week review with A1c, lipids and ALT. Next scheduled visit 2026-06-30: periodic adult preventive visit. [S]